SOURCE: StockCall

StockCall

July 20, 2011 09:00 ET

Analyst Research on Pfizer Inc. and Bristol-Myers Squibb Co. - Drug Manufacturers - Major Bracing for Patent Cliffs

JOHANNESBURG, SOUTH AFRICA--(Marketwire - Jul 20, 2011) - www.stockcall.com/ offers investors comprehensive research on the Drug Manufacturers - Major industry and has completed analytical research on Pfizer Inc. (NYSE: PFE) and Bristol-Myers Squibb Co. (NYSE: BMY). Register with us today at www.stockcall.com/ to have free access to these researches.

With several huge patent cliffs looming in the near-future, companies in the Drug Manufacturers - Major sector are adopting different strategies to ensure their own health once several drugs open up to generic copies. One major trend has been to focus on emerging healthcare markets where growth is strong in order to help offset upcoming domestic uncertainty. These markets have shown strong sales of off-patent drugs and companies like Pfizer Inc. are looking to take advantage. Pfizer just announced that it may sell its animal health and nutrition units to focus more readily on its established products. Investors looking for free research on Pfizer Inc. are welcome to sign up at www.stockcall.com/PFE2007611.pdf for our new report.

www.stockcall.com/ is an online platform where investors doing their due-diligence on the Drug Manufacturers - Major industry can have easy and free access to our analyst research and opinions on Pfizer Inc. and Bristol-Myers Squibb Co.; all investors need to do is register for a complimentary membership at https://stockcall.com/development/stockcall/page.php?name=register.html.

Meanwhile, other companies are touting the importance of research and development spending for future success despite their depression of earnings prior to regulatory approval. This comes at a time when governmental agencies are beginning to require more stringent proof for the safety and efficacy of drugs. The development process has often been so difficult that news like Bristol-Myers Squibb Co.'s recent strong data for a potential new blood thinner comes as welcomed news to investors. Investors looking for complimentary research on Bristol-Myers Squibb Co. are welcome to sign up at www.stockcall.com/BMY200711.pdf for our new report.

Whether through the expansion of pre-existing product lines or the development of new ones, the one thing that seems clear in the Drug Manufacturers - Major sector is that the upcoming patent cliffs are going to have widespread effects on the market. Register now at https://stockcall.com/development/stockcall/page.php?name=register.html to have free access to our reports on the Drug Manufacturers - Major industry.

About StockCall.com
StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines.

Contact Information